Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma
- 1 October 2025
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 84 (2) , 370-384
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82372714)
- National Natural Science Foundation of China (82303022)
- National Natural Science Foundation of China (82203380)
- National Natural Science Foundation of China (82122048)
- National Key Research and Development Program of China (2024YFE0215600)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515011416)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A04J6575)
This publication has 48 references indexed in Scilit:
- Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumorsCancer Cell, 2024
- A developmental constraint model of cancer cell states and tumor heterogeneityCell, 2024
- A transcription factor atlas of directed differentiationCell, 2023
- Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric EpendymomaCancer Cell, 2020
- Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceCancer Cell, 2020
- Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinomaHepatology, 2018
- Clonal Heterogeneity and Tumor Evolution: Past, Present, and the FutureCell, 2017
- Gene Copy-Number Alterations: A Cost-Benefit AnalysisCell, 2013
- Circuitry and Dynamics of Human Transcription Factor Regulatory NetworksCell, 2012
- Intracellular site of asialoglycoprotein receptor-ligand uncoupling: Double-label immunoelectron microscopy during receptor-mediated endocytosisCell, 1983